Commentary on Health service use and costs associated with fluoroquinolone-related tendon injuries

Pharmacol Res Perspect. 2021 Aug;9(4):e00821. doi: 10.1002/prp2.821.

Author

Michael Kennedy¹

Affiliation

¹ Department of Medicine and Clinical Pharmacology and Toxicology St Vincent's Hospital, University of New South Wales, Sydney, Australia.

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents
Fluoroquinolones*
Humans
Patient Acceptance of Health Care
Tendon Injuries*

Substances

Anti-Bacterial Agents
Fluoroquinolones